Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06402331
Title FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) (AlphaBreak)
Acronym AlphaBreak
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Fusion Pharmaceuticals Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Hoag Health Center Irvine RECRUITING Irvine California 92618 United States Details
VA Greater Los Angeles Healthcare System RECRUITING Los Angeles California 90073 United States Details
Biogenix Molecular, LLC RECRUITING Miami Florida 33165 United States Details
University of Iowa Hospitals and Clinics RECRUITING Iowa City Iowa 52242 United States Details
BAMF Health RECRUITING Grand Rapids Michigan 49503 United States Details
SSM Health Saint Louis University Hospital RECRUITING Saint Louis Missouri 63104 United States Details
XCancer RECRUITING Omaha Nebraska 68130 United States Details
New Mexico Oncology Hematology Consultants Ltd. RECRUITING Albuquerque New Mexico 87109 United States Details
Laura and Isaac Perlmutter Cancer Center at NYU Langone RECRUITING New York New York 10016 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field